Market expansion OmniActive operates across multiple regions (India, US, Europe) and has recently launched sleep and eye-health product lines, indicating openness to new categories and geographic markets. Sales opportunities exist in international nutraceuticals channels, contract manufacturing partnerships, and private-label collaborations to expand regional reach.

Innovation pipeline A history of science-backed actives and recent product introductions such as Fenavari and Sleeproot, plus eye-health soft chews developed with partners, suggests a strong R&D cadence. Target partnerships for ingredient supply, co-development, and branded ingredient solutions to leverage their IP-protected actives.

Strategic partnerships Active collaborations with ENovate Biolife for enXtra and with Sirio Pharma for eye-health formulations indicate a collaboration-friendly model. Opportunities exist for licensing, white-labeling, or joint development with retailers, supplement brands, and functional food/beverage manufacturers.

R&D focus Significant investments in R&D facilities and a robust product development trajectory imply a willingness to validate and bring new actives to market. This aligns with opportunities for sponsored research, clinical study partnerships, and higher-value ingredient sourcing for premium brand portfolios.

Marketing readiness Active participation in industry events and presence across digital platforms (PR, Vitafoods Europe, Eye Health Summit) signal strong go-to-market capability. Sales opportunities include demand-generation collaborations, presence at trade shows, and co-marketing programs to drive trial and adoption of new actives.